Chemo's hidden toll: new study tracks brain and nerve damage in breast cancer survivors
NCT ID NCT07184749
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will follow 100 newly diagnosed breast cancer patients in Egypt to see how chemotherapy affects their thinking, memory, and nerves. Researchers will use questionnaires and exams before treatment and one year later. The goal is to better understand these side effects in a population that hasn't been well-studied.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict and manage the cognitive and nerve side effects of chemotherapy in breast cancer patients.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve outcomes. Results may not apply to other populations or cancer types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sohag University
Sohag, 82524, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple